Results 61 to 70 of about 14,081 (169)

Radiation therapy for oligometastatic bone disease in breast cancer [PDF]

, 2020
Breast cancer (BCa) frequently metastasizes to the bone. BCa patients with oligometastatic bone diseases have much more favorable outcomes than those with metastatic bone disease.
Nagao, Ryota, Katayama, Norihisa, Katsui, Kuniaki, Watanabe, Kenta, Hiraki, Takao, Otsuki, Kaho, Kanazawa, Susumu   +6 more
core   +2 more sources

The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change

International Journal of Cancer, Volume 159, Issue 7, Page 1588-1601, 1 October 2026.
ABSTRACT The standard for assessing and recording the extent of the tumour, a necessity for most malignancies, is the Tumour Node Metastases (TNM) classification. The Union for International Cancer Control (UICC) TNM committee has defined this since the early 1950s.
James D. Brierley, Liesbet J. Van Eycken, Meredith E. Giuliani, Brian A. Rous, Shao Hui Huang, Hisao Asamura, Mary K. Gospodarowicz, Anne W. Lee, Brian O'Sullivan   +8 more
wiley   +1 more source

Complete response of a metastatic microsatellite-stable gastric cancer after neoadjuvant chemoimmunotherapy: should we still operate? A case report and review of the literature

Frontiers in Oncology
Gastric cancer often presents at an advanced stage in Western populations due to a lack of screening programs, leading to poor prognoses. Historically, palliative chemotherapy resulted in a median survival of 9.9 months.
Hiba Mechahougui, Mickael Chevallay, François Cauchy, Nicolas Chaveau, Giacomo Puppa, Thibaud Koessler, Stefan Monig   +6 more
doaj   +1 more source

Role of Consolidative Stereotactic Body Radiation Therapy in Oligoresistant/Oligoprogressive Pulmonary Parenchymal Metastases

Cancer Management and Research, 2022
Tanju Berber,1 Abdullah Sakin2 1Department of Radiation Oncology, Okmeydani Training and Research Hospital, Istanbul, Turkey; 2Department of Medical Oncology, Medipol University, Bahçelievler Medipol Hospital, Istanbul, TurkeyCorrespondence: Tanju Berber,
Berber T, Sakin A
doaj  

Colorectal Cancer: Epidemiology, Risk Factors, Signaling Pathways, Clinical Features, Screening, Diagnosis, and Management

MedComm, Volume 7, Issue 10, October 2026.
Colorectal cancer is a heterogeneous, adaptive disease shaped by population‐level risk, genomic and epigenetic alterations, tumor ecosystem evolution, and treatment pressure. This review integrates epidemiology, risk factors, signaling networks, clinical presentation, screening, molecular diagnosis, and stage‐ and biomarker‐guided management while ...
Kairui Wan, Ke Tang, Linglong Wang, Qin Tian, Mingwei Zheng, Cheng Qian, Limei Liu   +6 more
wiley   +1 more source

Classifying Oligometastatic Non-Small Cell Lung Cancer

, 2021
An oligometastatic cancer state was first postulated in the 1990s by Hellman and Weichselbaum and described limited metastatic spread to a single or few sites of disease.
Antonoff, Mara B., Mara B. Antonoff, Alisa N. Blumenthaler, Blumenthaler, Alisa N.   +3 more
core   +1 more source

Liver Metastases from Colorectal Cancer: From Pathogenesis to Current Treatment

MedComm, Volume 7, Issue 10, October 2026.
The liver is not merely a passive recipient of disseminated tumor cells, but a unique metastatic organ shaped by anatomical, metabolic, and immunological characteristics that support tumor colonization. Increasing evidence indicates that colorectal cancer liver metastasis development is driven by dynamic interactions between tumor intrinsic programs ...
Jialiang Fan, Huiru Zhang, Deyang Kong, Yu Sun, Shuaibing Lu, Wenjing Yang, Renshen Xiang, Qi Zhang, Wei Pei, Haizeng Zhang, Lin Feng   +10 more
wiley   +1 more source

Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer

, 2017
The oligometastatic state represents a distinct entity among those with metastatic disease and consists of patients with metastases limited in number and location, representing an intermediate state between locally confined and widely metastatic cancer ...
Sanjay Popat, Juan, Oscar, Popat, Sanjay, Oscar Juan   +3 more
core   +1 more source

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer

Frontiers in Oncology, 2020
Purpose/Objective: Oligometastatic disease (OMD) and oligoprogressive disease (OPD) describe tumor states with a limited metastasization. In contrast to other disease states, treatment of OMD or OPD has not yet become common for breast cancer.
Fabian Weykamp, Fabian Weykamp, Fabian Weykamp, Laila König, Laila König, Laila König, Katharina Seidensaal, Katharina Seidensaal, Katharina Seidensaal, Tobias Forster, Tobias Forster, Tobias Forster, Philipp Hoegen, Philipp Hoegen, Philipp Hoegen, Sati Akbaba, Sati Akbaba, Sati Akbaba, Stephan Mende, Stephan Mende, Stephan Mende, Stefan E. Welte, Stefan E. Welte, Stefan E. Welte, Thomas M. Deutsch, Andreas Schneeweiss, Jürgen Debus, Jürgen Debus, Jürgen Debus, Jürgen Debus, Jürgen Debus, Jürgen Debus, Juliane Hörner-Rieber, Juliane Hörner-Rieber, Juliane Hörner-Rieber, Juliane Hörner-Rieber   +35 more
doaj   +1 more source

Management of De Novo miN1 Prostate Cancer in the PSMA‐PET Era

The Prostate, Volume 86, Issue 14, Page 1404-1412, October 2026.
ABSTRACT Background Prostate‐specific membrane antigen positron emission tomography (PSMA‐PET) is reshaping nodal staging in prostate cancer by detecting regional lymph node metastases with greater accuracy than conventional imaging. This has created a new cohort of patients with N1M0 disease detectable only on advanced imaging, raising important ...
Thomas McMaster, Caitlin Ying Ming Louey, Jordan Santucci, Chloe Hobson, David D. Chen, Niranjan Sathianathen, Joseph Ischia, Damien M. Bolton, Nathan Lawrentschuck, Declan G. Murphy, Shankar Siva, Marlon Perera   +11 more
wiley   +1 more source